| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/10/2009 | CN100496493C 2-amino-4, 5-trisubstituted thiazolyl derivatives |
| 06/10/2009 | CN100496485C Antineoplastic combinations |
| 06/10/2009 | CN100496298C Process for producing liquid formulation containing raw yeast and liquid formulation |
| 06/09/2009 | US7544839 N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide; nervous system disorders; melatoninergic system disorders; industrial synthesis |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544799 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 06/09/2009 | US7544784 The invention provides methods of increasing yields of desired conformation of proteins. In particular embodiments, the invention includes contacting preparations of a recombinant protein with a reduction/oxidation coupling reagent for a time sufficient to increase the relative proportion of a desired co |
| 06/09/2009 | US7544711 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents |
| 06/09/2009 | US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/09/2009 | US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 06/09/2009 | US7544689 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors |
| 06/09/2009 | US7544682 cancer; Methyl 5-((7-(((tert-butylamino)carbonyl)amino)-6-(2,6-dichlorophenyl)pyrido[2,3-d] pyrimidin-2-yl)amino)-1,3-benzodioxole-2-carboxylate; treating cellular proliferation disorders |
| 06/09/2009 | US7544681 with organic acids selected to reduce the side effects induced by the psychotropic drugs and/or to exert anti-proliferative activity |
| 06/09/2009 | US7544677 Cancer; 2-(methylthio)-6-phenyl-7-(4-{[4-(5-pyridin-2-yl-4H-1,2,4-triazol-3-yl)piperidin-1-yl]methyl}phenyl)pyrido[2,3-d]pyrimidine;serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544497 Modulating sirtuin deacetylase protein; apoptosis; using flavone, stilbene, isoflavone, sphingosine; stroke; cardiovascular disorders; antiarthritic agents; Alzheimer's disease |
| 06/09/2009 | US7544480 drug screening an antagonist which inhibits hydroxylation of hypoxia inducible factor or an agonist which promotes hydroxylation of hypoxia inducible factor; hydroxylation of asparagine; antitumor agent; use for radiotherapy or chemotherapy |
| 06/09/2009 | US7544374 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/09/2009 | CA2481005C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 06/09/2009 | CA2438141C Noninvasive measurements of chemical substances |
| 06/09/2009 | CA2424470C Treatment of gastrointestinal stromal tumors |
| 06/09/2009 | CA2403721C Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/09/2009 | CA2382886C Benzamide formulation with histone deacetylase inhibitor activity |
| 06/09/2009 | CA2352229C Glyceryl nucleotides, method for the production thereof and their use |
| 06/09/2009 | CA2251355C Il-6 mutein |
| 06/09/2009 | CA2155017C Vpr function and activity |
| 06/04/2009 | WO2009070652A1 Method of treating cancer |
| 06/04/2009 | WO2009070609A2 Therapeutic targeting of il-6 using sirna in neutral liposomes |
| 06/04/2009 | WO2009070567A1 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
| 06/04/2009 | WO2009070551A1 Use of somatostatin analogs in meningioma |
| 06/04/2009 | WO2009070524A1 Pyrrolo[3,2-d]pyrimidine compounds and their use as pi3 kinase and mtor kinase inhibitors |
| 06/04/2009 | WO2009070516A1 Imidazo-thiazole derivatives as protein kinase inhibitors |
| 06/04/2009 | WO2009070378A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | WO2009070331A2 Compounds and methods for the selective inhibition of abcb1, abcc1 and abcg2 transporters and the treatment of cancers, especially drug resistant cancers and high throughput flow cytometry assay to detect selective inhibitors |
| 06/04/2009 | WO2009070294A2 Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof |
| 06/04/2009 | WO2009070244A2 Methods for inhibiting fascin |
| 06/04/2009 | WO2009070045A2 Imidazole derivatives, process for their preparation, and thier pharmaceutical use |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069680A1 Medicinal composition for treating gastrointestinal stromal tumor (gist) and kit and method for estimating the prognosis of patient suffering from gastrointestinal stromal tumor |
| 06/04/2009 | WO2009069668A1 Agent for increasing the expression of malignant melanoma antigen, and use thereof |
| 06/04/2009 | WO2009069302A1 Stat3 epitope peptides |
| 06/04/2009 | WO2009069291A1 Prophylactic and/or therapeutic composition for disease caused by inhalation of tobacco smoke |
| 06/04/2009 | WO2009069140A1 An improved process for preparation of letrozole and its intermediates |
| 06/04/2009 | WO2009068955A2 Polymorphs of a c-met/hgfr inhibitor |
| 06/04/2009 | WO2009068916A1 Naphthalene diimide compounds interacting with g-quadruplex regions in dna |
| 06/04/2009 | WO2009068906A2 Combinations comprising zd4054 and a src family kinase inhibitor 172 |
| 06/04/2009 | WO2009068649A2 Antigen-binding constructs |
| 06/04/2009 | WO2009068625A2 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors |
| 06/04/2009 | WO2009068204A1 Anti-mesothelin antibodies and uses therefor |
| 06/04/2009 | WO2009068190A2 Combinations comprising a prostaglandin and uses thereof |
| 06/04/2009 | WO2009067891A1 Water-soluble triterpenephenol compounds having antitumor activity and the preparation thereof |
| 06/04/2009 | WO2009067856A1 Histone deacetylase inhibitor, composition and use thereof |
| 06/04/2009 | WO2009067808A1 Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors |
| 06/04/2009 | WO2009067800A1 Antibodies against a cancer-associated epitope of variant nfkbib and uses thereof |
| 06/04/2009 | WO2009067767A2 Targeted radiotherapy |
| 06/04/2009 | WO2009052081A3 Antibodies that bind il-4 and/or il-13 and their uses |
| 06/04/2009 | WO2009051555A3 Modified mhc class i binding peptides |
| 06/04/2009 | WO2009050267A3 Il24 for inducing hyperproliferative or autoimmune cell death |
| 06/04/2009 | WO2009045992A3 C-met protein kinase inhibitors |
| 06/04/2009 | WO2009040817A3 Salarins and tulearins, compositions and uses thereof |
| 06/04/2009 | WO2009040022A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009038879A3 Stem cell differentiating agents and uses therefor |
| 06/04/2009 | WO2009033815A3 Use of the peptide combination ala-pro-gly-pro-arg with cecropin a as a therapeutic agent |
| 06/04/2009 | WO2009033734A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009033657A3 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents |
| 06/04/2009 | WO2009004427A3 Benzimidazole derivatives |
| 06/04/2009 | WO2008141111A3 Polymers conjugated with platinum drugs |
| 06/04/2009 | WO2008141110A3 Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs |
| 06/04/2009 | WO2008101195A4 Drug resistance reversal in neoplastic disease |
| 06/04/2009 | WO2008045346A3 Recombinant modified vaccinia ankara encoding a her-2 antigen for use in treating cancer |
| 06/04/2009 | WO2001060458A3 Inhibitors of prenyl-protein transferase |
| 06/04/2009 | US20090144841 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications |
| 06/04/2009 | US20090143486 Charge reversible polymers |
| 06/04/2009 | US20090143467 Anticancer agents based on regulation of protein prenylation |
| 06/04/2009 | US20090143466 Isolation of Atraric Acid, Synthesis of Atraric Acid Derivatives, and Use of Atraric Acid and the Derivatives Thereof for the Treatment of Benign Prostatic Hyperplasia, Prostate Carcinoma and Spinobulbar Muscular Atrophy |
| 06/04/2009 | US20090143464 Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent |
| 06/04/2009 | US20090143462 Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same |
| 06/04/2009 | US20090143455 Pyrazoles Useful in the Treatment of Inflammation |
| 06/04/2009 | US20090143446 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof |
| 06/04/2009 | US20090143438 Novel Pyridine Derivative Having Anti-Helicobacter Pylori Activity |
| 06/04/2009 | US20090143424 Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors |
| 06/04/2009 | US20090143421 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 06/04/2009 | US20090143420 2-benzoylimidazopyridine derivatives, preparation and therapeutic use thereof |
| 06/04/2009 | US20090143417 Methods of treating pain |
| 06/04/2009 | US20090143412 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders |
| 06/04/2009 | US20090143411 Thiophens and Their Use as Anti-Tumor Agents |
| 06/04/2009 | US20090143400 Purine derivatives having immuno-modulating properties |
| 06/04/2009 | US20090143399 Protein Kinase Inhibitors |
| 06/04/2009 | US20090143389 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090143384 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer |
| 06/04/2009 | US20090143379 Storage stable perfusion solution for dihydropteridinones |
| 06/04/2009 | US20090143376 Fused Heterocyclic Compounds and Their Use as Sirtuin Modulators |
| 06/04/2009 | US20090143375 Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical Agents |
| 06/04/2009 | US20090143374 Use of Compounds and Compositions for the Treatment of Amyloid Diseases |
| 06/04/2009 | US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 06/04/2009 | US20090143364 Chiral cis-imidazolines |
| 06/04/2009 | US20090143357 Heteroaryl urea derivatives useful for inhibiting chk1 |
| 06/04/2009 | US20090143355 Substituted aryl-amine derivatives and methods of use |
| 06/04/2009 | US20090143342 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |